Stimulation of glucose and amino acid transport and activation of the insulin signaling pathways by insulin lispro in L6 skeletal muscle cells

Clinical Therapeutics

Volumn 20, Issue 1, 1998, Pages 125-140

  Somwar, Romel ^a,b   Sweeney, Gary ^a   Ramlal, Toolsie ^a   Klip, Amira ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Amino acid; Glucose transport; Lispro; p70 S6 kinase; Wortmannin

Indexed keywords

2 METHYL 2 METHYLAMINOPROPIONIC ACID; AMINO ACID; DEOXYGLUCOSE; GLUCOSE; HUMAN INSULIN; INSULIN; INSULIN LISPRO; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; WORTMANNIN;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GLUCOSE TRANSPORT; MUSCLE CELL; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 0031906001     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(98)80040-4     Document Type: Article

References (37)

1. Howey DC, Hooper SA, Bowsher RR. [Lys(B28), Pro(B29)]-human insulin: An equipotent analog of human insulin with rapid onset and short duration of action. Diabetes. 1991;40(Suppl 1):423A. Abstract.
2. Brems DN. The role of insulin's C-terminal B-chain on association, folding and stability. Papers Am Chem Soc. 1991;202: 132. Abstract.
3. Radziuk J, Candas B, Davies J, et al. The absorption kinetics of subcutaneously injected insulin and two monomeric analogs. Diabetologia. 1992;35:A3. Abstract.
4. Shaw WN, Su KSE. Biological aspects of a new insulin analog [Lys(B28), Pro (B29)]-human insulin. Diabetes. 1991;40: 464A. Abstract.
5. Slieker LJ, Sundell K. Modifications in the 28-29 positions of the insulin B-chain alter binding to the IGF-1 receptor with minimal effect on the insulin receptor binding. Diabetes. 1990;39:118A. Abstract.
6. Mitsumoto Y, Klip A. Developmental regulation of the subcellular distribution and glycosylation of GLUT1 and GLUT4 glucose transporters during myogenesis of L6 muscle cells. J Biol Chem. 1992;267: 4957-4962.
7. Walker PS, Ramlal T, Sarabia V, et al. Glucose transport activity in L6 muscle cells is regulated by the coordinate control of subcellular glucose transporter distribution, biosynthesis, and mRNA transcription. J Biol Chem. 1990;265: 1516-1523.
8. Tsakiridis T, Vranic M, Klip A. Phosphatidylinositol 3-kinase and the actin network are not required for the stimulation of glucose transport caused by mitochondrial uncoupling: Comparison with insulin action. Biochem J. 1995;309:1-5.
9. Klip A, Li G, Logan WJ. Induction of sugar uptake response to insulin by serum depletion in fusing L6 myotubes. Am J Physiol. 1984;247:E494-E499.
10. 3H]cytochalasin B binding sites. Biochim Biophvs Acta. 1982;687:265-280.
11. Hundal HS, Ramlal T, Reyes R, et al. Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology. 1992;131:1165-1173.
12. Tsakiridis T, McDowell HE, Walker T, et al. Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport and glucose transporters in L6 skeletal muscle cells. Endocrinology. 1995;136:4315-4322.
13. Guma A, Castello A, Testar X, et al. Differential sensitivity of insulin and adaptive regulation-induced system A activation to microtubular function in skeletal muscle. Biochem J. 1992;281:407-411.
14. White MF, Kahn CR. The insulin signaling system. J Biol Chem. 1994;269:1-4.
15. Kasuga M, Karlsson FA, Kahn CR. Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science. 1982;215:185-187.
16. White MF, Maron R, Kahn CR. Insulin rapidly stimulates tyrosine phosphorylation of a Mr 185,000 protein in intact cells. Nature. 1985;318:183-186.
17. Yaffe D. Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc Natl Acad Sci USA. 1968;61:477-483.
18. Bilan PJ, Mitsumoto Y, Maher F, et al. Detection of the GLUT3 glucose transporter in rat L6 muscle cells: Regulation by cellular differentiation, insulin and insulin-like growth factor I. Biochem Biophys Res Commun. 1992;186:1129-1137.
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilising the principle of protein-dye binding. Ann Biochem. 1976;72:247-254.
20. Hundal HS, Bilan PJ, Tsakiridis T, et al. Structural disruption of the trans-Golgi network does not interfere with the acute stimulation of glucose and amino acid uptake by insulin-like growth factor-1 in muscle cells. Biochem J. 1994;297: 289-295.
21. Cowley S, Paterson H, Kemp P. Marshall CJ. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 1994;77:841-852.
22. Yano H, Nakanishi S, Kimura K, et al. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem. 1993;268:25846-25856.
23. Yeh J, Gulves EA, Rameh L, Birnbaum MJ. The effects of wortmannin on rat skeletal muscle. J Biol Chem. 1995;270: 2107-2111.
24. Clarke JF, Young PW, Yonezawa K, et al. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem J. 1994;300:631-635.
25. Guma A, Mora C, Santalucia T, et al. System A transport activity is stimulated in skeletal muscle in response to diabetes. FEBS Lett. 1992;310:51-54.
26. Keller SR, Lienhard GE. Insulin signalling: The role of insulin receptor substrate 1. Trends Cell Biol. 1994;4:115-118.
27. Shepherd PR, Nave BT, O'Rahilly S. The role of phosphoinositide 3-kinase in insulin signalling. J Mol Endocrinol. 1996; 17:175-184.
28. Saltiel AR. Diverse signaling pathways in the cellular actions of insulin. Am J Physiol. 1996;270:E375-E385.
29. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem. 1995; 270:14843-14846.
30. Proud CG. P70 S6 kinase: Enigma with variations. Trends Biochem Sci. 1996;21: 181-185.
31. Taha C, Mitsumoto Y, Skolnik EY, Klip A. The insulin-dependent biosynthesis of GLUT1 and GLUT3 glucose transporters of L6 muscle cells is mediated by different pathways: Roles of pp70 S6 kinase and Ras. J Biol Chem. 1995;270: 24678-24681.
32. Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signalling by the 70 kD S6 protein kinases. Cell. 1992;69:1227-1236.
33. Ferrari S, Bannwarth W, Morley SJ, et al. Activation of p70s6k is associated with phosphory lation of four clustered sites displaying Ser/Thr-Pro motifs. Proc Natl Acad Sci USA. 1992;89:3325-3335.
34. Trautman ME. Effect of the insulin analogue [Lys(B28), Pro(B29)] on blood glucose control. Horm Metab Res. 1994;26: 588-590.
35. Zinman B, Tildesley H, Chiasson J, et al. Insulin lispro in CSH: Results of a double-blind crossover study. Diabetes. 1997; 46:440-443.
36. Lahtela TT, Knip M, Paul R, et al. Severe antibody-mediated human insulin resistance: Successful treatment with the insulin analog lispro. Diabetes Care. 1997; 20:71-73.
37. Henrichs HR, Unger H, Trautman ME, Pfutzner A. Severe insulin resistance treated with insulin lispro. Lancet. 1996; 348:1248.